ANNOUNCEMENT 01 Oct 2011
In October 2011, the government of Pakistan initiated a new anti-dumping investigation.NUMBER OF INTERVENTIONS
1
SOURCE
WTO semi-annual report on antidumping. Document: G/ADP/N/237/PAK
WTO, Committee on Anti-Dumping Practices, Semi-annual Report under Article 16.4, Pakistan, 28.02.2014 (Document G/ADP/N/252/PAK):
https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S006.aspx?Query=(%40Symbol%3d+g%2fadp%2fn*+and+%40Title%3d+report*+and+semi*+)+and+(+%40DocumentDate+%3e%3d+2014%2f01%2f01+00%3a00%3a00+)+and+(+%40DocumentDate+%3c%3d+2014%2f12%2f31+23%3a59%3a59+)&Language=ENGLISH&Context=FomerScriptedSearch&languageUIChanged=true#
Government of Pakistan, National Tariff Commission, ADC No. 29/2012/NTC/PIA of 17 January 2015: http://ntc.gov.pk/wp-content/uploads/2016/05/060215-Notice-of-Conclusion-16-01-15.pdf
On December 14, 2012, the Pakistani authorities initiated an anti-dumping investigation on imports of pegylated interferon alpha-2A from Switzerland.
The products subject to investigation are classified under the following HS code: 3002.2090. The dumping is suspected to have occurred between October 1, 2011 and September 30, 2012.
On July 27, 2013, the Pakistani authorities made a preliminary determination of dumping. The dumping margin is 27.58%. However, no provisional duty was imposed.
The Sindh High Court has granted stay in this investigation.
On 17 January 2015, theNational Tariff Commission concluded the above investigation without the imposition of duties.